Nawel Bourayou

MONARCH 3: Abemaciclib As Initial Therapy for Advanced Breast Cancer

Matthew P. Goetz, Masakazu Toi, Mario Campone et al. · Journal of Clinical Oncology · 2017 · 1.7K citations · Full text

Medicine, Oncology, Pharmacology +16

MONARCH 2: Abemaciclib in Combination With Fulvestrant in Women With HR+/HER2− Advanced Breast Cancer Who Had Progressed While Receiving Endocrine Therapy

George W. Sledge, Masakazu Toi, Patrick Neven et al. · Journal of Clinical Oncology · 2017 · 1.7K citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Pemetrexed and carboplatin, an active option in first-line treatment of elderly patients with advanced non-small cell lung cancer (NSCLC): A phase II trial

Radj Gervais, G. Robinet, Christelle Clément-Duchêne et al. · Lung Cancer · 2013 · 34 citations

Medicine, Oncology, Pharmacology +10

Feasibility of home delivery of pemetrexed in patients with advanced non-squamous non-small cell lung cancer

Rohit Lal, Gunnar Hillerdal, Riyaz Shah et al. · Lung Cancer · 2015 · 22 citations

Pharmacy, Oncology, Pharmacotherapy +8

MONARCH 3: Abemaciclib as initial therapy for patients with HR+/HER2- advanced breast cancer

Angelo Di Leo, Masakazu Toi, Mario Campone et al. · Annals of Oncology · 2017 · 21 citations

Medicine, Oncology, Breast Oncology +15